In 2019, we began a 50-patient pilot trial in partnership with Perthera, an organization focused on improving patient outcomes through artificial intelligence and data-driven cancer therapy recommendations for any patient, anywhere.
In this pilot, we built upon our previous work dedicated to providing precision medicine to metastatic breast cancer patients and combined it with Perthera’s robust precision oncology platform to get treatment solutions into the hands of the people that need it the most.